{"title": "Efectos de la logopedia en pacientes hipertensos", "author": null, "url": "https://ichgcp.net/es/clinical-trials-registry/NCT02681484", "hostname": "ichgcp.net", "description": "Se ha demostrado que la terapia del habla antropos\u00f3fica (ATS) influye positivamente en la variabilidad de la frecuencia card\u00edaca (HRV) y la coordinaci\u00f3n de la f.... Registro de ensayos cl\u00ednicos. ICH GCP.", "sitename": "ichgcp.net", "date": "2015-10-30", "id": null, "license": null, "body": null, "comments": "", "commentsbody": null, "raw_text": null, "text": "Efectos de la logopedia en pacientes hipertensos\n[Klinik Arlesheim](https://ichgcp.net/es/clinical-trials-registry/research/list?spons=Klinik%20Arlesheim)\nRespiraci\u00f3n guiada por el habla: \u00bfuna modalidad para influir en la regulaci\u00f3n cardiovascular y la percepci\u00f3n de salud en pacientes hipertensos?\nDescripci\u00f3n general del estudio\nEstado\nCondiciones\nIntervenci\u00f3n / Tratamiento\nDescripci\u00f3n detallada\nEn este estudio prospectivo, principalmente previo y posterior, los pacientes recibieron tres tratamientos ATS en alternancia con tres sesiones de control (conversaci\u00f3n informal con el terapeuta). Para realizar el an\u00e1lisis HRV y la determinaci\u00f3n de BRS, la presi\u00f3n arterial y el ECG se registraron continuamente durante las sesiones. Los cambios en el bienestar subjetivo y la salud percibida se evaluaron mediante un cuestionario antes y despu\u00e9s de las distintas sesiones (cuestionario de estado de \u00e1nimo).\nTreinta y un pacientes participaron en este estudio, la mayor\u00eda con diagn\u00f3stico de hipertensi\u00f3n arterial (22 de 31).\nTipo de estudio\nInscripci\u00f3n (Actual)\nFase\n- No aplica\nCriterios de participaci\u00f3n\nCriterio de elegibilidad\nEdades elegibles para estudiar\nAcepta Voluntarios Saludables\nG\u00e9neros elegibles para el estudio\nDescripci\u00f3n\nCriterios de inclusi\u00f3n:\n- Indicaci\u00f3n de logopedia\n- Dispuesto y capaz de realizar terapia del habla.\n- Tratamiento ambulatorio u hospitalizaci\u00f3n planificada durante al menos 14 d\u00edas.\n- Diagnosticado con hipertensi\u00f3n (I 10, ya sea en terapia con medicamentos o verificada por mediciones de presi\u00f3n arterial de 24 horas), con cefalea tensional (G 44.2) o con ansiedad (F 41) confirmada por el m\u00e9dico reclutador\n- Ninguna alteraci\u00f3n en la medicaci\u00f3n que afecte a la HRV durante los \u00faltimos 2 meses antes y durante el estudio\nCriterio de exclusi\u00f3n:\n- Comorbilidad que influye fuertemente en la VFC\n- Demasiado d\u00e9bil para participar en una terapia activa\n- Marcapasos\n- Enfermedad de la piel o alergias que impidan el uso de electrodos de ECG\nPlan de estudios\n\u00bfC\u00f3mo est\u00e1 dise\u00f1ado el estudio?\nDetalles de dise\u00f1o\n- Prop\u00f3sito principal: TRATAMIENTO\n- Asignaci\u00f3n: NO_ALEATORIZADO\n- Modelo Intervencionista: FACTORIAL\n- Enmascaramiento: NINGUNO\nArmas e Intervenciones\n|\n|\nGrupo de participantes/brazo\n|\n|\nIntervenci\u00f3n / Tratamiento\n|\n|\nEXPERIMENTAL: Hipertenso\nPacientes diagnosticados con hipertensi\u00f3n (I10, ya sea en terapia farmacol\u00f3gica o verificada por mediciones de presi\u00f3n arterial de 24 horas) administrados a terapia del habla antropos\u00f3fica (intervenci\u00f3n).\n|\n|\nLa terapia del habla antropos\u00f3fica utiliza combinaciones de sonidos como \"KLSFM\" u \"OM\" y versos hex\u00e1metros en alem\u00e1n, pronunciados por el terapeuta e imitados por los pacientes, para expandir y desacelerar la respiraci\u00f3n. La intervenci\u00f3n es realizada por el mismo terapeuta calificado para un paciente en d\u00edas diferentes pero durante el mismo d\u00eda durante 30 minutos en posici\u00f3n vertical y caminando.\nOtros nombres:\n|\n|\nCOMPARADOR_ACTIVO: Normotenso\nPacientes diagnosticados de cefalea tensional (G 44.2) o trastornos de ansiedad (F41) administrados a logopedia antropos\u00f3fica (intervenci\u00f3n).\n|\n|\nLa terapia del habla antropos\u00f3fica utiliza combinaciones de sonidos como \"KLSFM\" u \"OM\" y versos hex\u00e1metros en alem\u00e1n, pronunciados por el terapeuta e imitados por los pacientes, para expandir y desacelerar la respiraci\u00f3n. La intervenci\u00f3n es realizada por el mismo terapeuta calificado para un paciente en d\u00edas diferentes pero durante el mismo d\u00eda durante 30 minutos en posici\u00f3n vertical y caminando.\nOtros nombres:\n\u00bfQu\u00e9 mide el estudio?\nMedidas de resultado primarias\n|\n|\nMedida de resultado\n|\n|\nMedida Descripci\u00f3n\n|\n|\nPeriodo de tiempo\n|\n|\nCambio de la sensibilidad barorrefleja previa al descanso despu\u00e9s de la intervenci\u00f3n y el reposo.\nPeriodo de tiempo: 30min en total por sesi\u00f3n. Seis sesiones por paciente en total.\n|\n|\nSensibilidad del reflejo baro a trav\u00e9s de la medici\u00f3n continua de la presi\u00f3n arterial mediante el m\u00e9todo de fijaci\u00f3n de volumen (no invasivo)\n|\n|\n30min en total por sesi\u00f3n. Seis sesiones por paciente en total.\nMedidas de resultado secundarias\n|\n|\nMedida de resultado\n|\n|\nMedida Descripci\u00f3n\n|\n|\nPeriodo de tiempo\n|\n|\nCambio de la variabilidad de la frecuencia card\u00edaca previa al descanso despu\u00e9s de la intervenci\u00f3n y el reposo\nPeriodo de tiempo: Medici\u00f3n durante toda la sesi\u00f3n (60min en total). Seis sesiones por paciente en total.\n|\n|\nMediciones de la variabilidad de la frecuencia card\u00edaca a trav\u00e9s de un registrador de ECG port\u00e1til\n|\n|\nMedici\u00f3n durante toda la sesi\u00f3n (60min en total). Seis sesiones por paciente en total.\nColaboradores e Investigadores\nPatrocinador\nColaboradores\nInvestigadores\n- Director de estudio: Christoph Kaufmann, PhD, Chief physician\nPublicaciones y enlaces \u00fatiles\nPublicaciones Generales\n-\n[Simoes-Wust AP, Rist L, Dettling M. Self-reported health characteristics and medication consumption by CAM users and nonusers: a Swiss cross-sectional survey. J Altern Complement Med. 2014 Jan;20(1):40-7. doi: 10.1089/acm.2012.0762. Epub 2013 Jul 17.](https://ichgcp.net/es/clinical-trials-registry/publications/134925-self-reported-health-characteristics-and-medication-consumption-by-cam-users-and-nonusers-a-swiss)\n-\n[Brook RD, Appel LJ, Rubenfire M, Ogedegbe G, Bisognano JD, Elliott WJ, Fuchs FD, Hughes JW, Lackland DT, Staffileno BA, Townsend RR, Rajagopalan S; American Heart Association Professional Education Committee of the Council for High Blood Pressure Research, Council on Cardiovascular and Stroke Nursing, Council on Epidemiology and Prevention, and Council on Nutrition, Physical Activity. Beyond medications and diet: alternative approaches to lowering blood pressure: a scientific statement from the american heart association. Hypertension. 2013 Jun;61(6):1360-83. doi: 10.1161/HYP.0b013e318293645f. Epub 2013 Apr 22.](https://pubmed.ncbi.nlm.nih.gov/23608661)\n-\n[Mancia G, Grassi G, Giannattasio C, Seravalle G. Sympathetic activation in the pathogenesis of hypertension and progression of organ damage. Hypertension. 1999 Oct;34(4 Pt 2):724-8. doi: 10.1161/01.hyp.34.4.724.](https://pubmed.ncbi.nlm.nih.gov/10523349)\n-\n[Mancia G, Grassi G. Mechanisms and clinical implications of blood pressure variability. J Cardiovasc Pharmacol. 2000;35(7 Suppl 4):S15-9. doi: 10.1097/00005344-200000004-00003.](https://pubmed.ncbi.nlm.nih.gov/11346215)\n-\n[Jonas WB. Reframing placebo in research and practice. Philos Trans R Soc Lond B Biol Sci. 2011 Jun 27;366(1572):1896-904. doi: 10.1098/rstb.2010.0405.](https://ichgcp.net/es/clinical-trials-registry/publications/134926-reframing-placebo-in-research-and-practice)\n-\n[Bernardi L, Sleight P, Bandinelli G, Cencetti S, Fattorini L, Wdowczyc-Szulc J, Lagi A. Effect of rosary prayer and yoga mantras on autonomic cardiovascular rhythms: comparative study. BMJ. 2001 Dec 22-29;323(7327):1446-9. doi: 10.1136/bmj.323.7327.1446.](https://ichgcp.net/es/clinical-trials-registry/publications/134927-effect-of-rosary-prayer-and-yoga-mantras-on-autonomic-cardiovascular-rhythms-comparative-study)\n-\n[Cysarz D, von Bonin D, Brachmann P, Buetler S, Edelhauser F, Laederach-Hofmann K, Heusser P. Day-to-night time differences in the relationship between cardiorespiratory coordination and heart rate variability. Physiol Meas. 2008 Nov;29(11):1281-91. doi: 10.1088/0967-3334/29/11/004. Epub 2008 Oct 9.](https://pubmed.ncbi.nlm.nih.gov/18843164)\n-\n[von Bonin D, Grote V, Buri C, Cysarz D, Heusser P, Moser M, Wolf U, Laederach K. Adaption of cardio-respiratory balance during day-rest compared to deep sleep--an indicator for quality of life? Psychiatry Res. 2014 Nov 30;219(3):638-44. doi: 10.1016/j.psychres.2014.06.004. Epub 2014 Jun 9.](https://pubmed.ncbi.nlm.nih.gov/25011731)\n-\n[Villa MP, Calcagnini G, Pagani J, Paggi B, Massa F, Ronchetti R. Effects of sleep stage and age on short-term heart rate variability during sleep in healthy infants and children. Chest. 2000 Feb;117(2):460-6. doi: 10.1378/chest.117.2.460.](https://pubmed.ncbi.nlm.nih.gov/10669691)\n-\n[Sztajzel J. Heart rate variability: a noninvasive electrocardiographic method to measure the autonomic nervous system. Swiss Med Wkly. 2004 Sep 4;134(35-36):514-22. doi: 10.4414/smw.2004.10321.](https://ichgcp.net/es/clinical-trials-registry/publications/57931-heart-rate-variability-a-noninvasive-electrocardiographic-method-to-measure-the-autonomic-nervous)\n-\n[Berntson GG, Bigger JT Jr, Eckberg DL, Grossman P, Kaufmann PG, Malik M, Nagaraja HN, Porges SW, Saul JP, Stone PH, van der Molen MW. Heart rate variability: origins, methods, and interpretive caveats. Psychophysiology. 1997 Nov;34(6):623-48. doi: 10.1111/j.1469-8986.1997.tb02140.x.](https://pubmed.ncbi.nlm.nih.gov/9401419)\n-\n[Heart rate variability. Standards of measurement, physiological interpretation, and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Eur Heart J. 1996 Mar;17(3):354-81. No abstract available.](https://pubmed.ncbi.nlm.nih.gov/8737210)\n-\n[Oka H, Mochio S, Yoshioka M, Morita M, Inoue K. Evaluation of baroreflex sensitivity by the sequence method using blood pressure oscillations and R-R interval changes during deep respiration. Eur Neurol. 2003;50(4):230-43. doi: 10.1159/000073865.](https://pubmed.ncbi.nlm.nih.gov/14634268)\n-\n[Walchli C, Saltzwedel G, Kruerke D, Kaufmann C, Schnorr B, Rist L, Eberhard J, Decker M, Simoes-Wust AP. Physiologic effects of rhythmical massage: a prospective exploratory cohort study. J Altern Complement Med. 2014 Jun;20(6):507-15. doi: 10.1089/acm.2012.0833. Epub 2013 May 23.](https://pubmed.ncbi.nlm.nih.gov/23700977)\n-\n[Seifert G, Driever PH, Pretzer K, Edelhauser F, Bach S, Laue HB, Langler A, Musial-Bright L, Henze G, Cysarz D. Effects of complementary eurythmy therapy on heart rate variability. Complement Ther Med. 2009 Jun;17(3):161-7. doi: 10.1016/j.ctim.2008.09.005. Epub 2008 Nov 20.](https://pubmed.ncbi.nlm.nih.gov/19398070)\n-\n[Cysarz D, von Bonin D, Lackner H, Heusser P, Moser M, Bettermann H. Oscillations of heart rate and respiration synchronize during poetry recitation. Am J Physiol Heart Circ Physiol. 2004 Aug;287(2):H579-87. doi: 10.1152/ajpheart.01131.2003. Epub 2004 Apr 8.](https://ichgcp.net/es/clinical-trials-registry/publications/134928-oscillations-of-heart-rate-and-respiration-synchronize-during-poetry-recitation)\n-\n[Bettermann H, von Bonin D, Fruhwirth M, Cysarz D, Moser M. Effects of speech therapy with poetry on heart rate rhythmicity and cardiorespiratory coordination. Int J Cardiol. 2002 Jul;84(1):77-88. doi: 10.1016/s0167-5273(02)00137-7.](https://pubmed.ncbi.nlm.nih.gov/12104068)\n-\n[von Bonin D, Fruhwirth M, Heuser P, Moser M. [Effects of speech therapy with poetry on heart rate variability and well-being]. Forsch Komplementarmed Klass Naturheilkd. 2001 Jun;8(3):144-60. doi: 10.1159/000057212. German.](https://pubmed.ncbi.nlm.nih.gov/11509858)\n-\n[Grossman E, Grossman A, Schein MH, Zimlichman R, Gavish B. Breathing-control lowers blood pressure. J Hum Hypertens. 2001 Apr;15(4):263-9. doi: 10.1038/sj.jhh.1001147.](https://pubmed.ncbi.nlm.nih.gov/11319675)\n-\n[Moser M, Fruhwirth M, Penter R, Winker R. Why life oscillates--from a topographical towards a functional chronobiology. Cancer Causes Control. 2006 May;17(4):591-9. doi: 10.1007/s10552-006-0015-9.](https://pubmed.ncbi.nlm.nih.gov/16596315)\n-\n[Parati G, Ochoa JE, Bilo G. Blood pressure variability, cardiovascular risk, and risk for renal disease progression. Curr Hypertens Rep. 2012 Oct;14(5):421-31. doi: 10.1007/s11906-012-0290-7.](https://pubmed.ncbi.nlm.nih.gov/22903810)\n-\n[Gillette MU, Sejnowski TJ. Physiology. Biological clocks coordinately keep life on time. Science. 2005 Aug 19;309(5738):1196-8. doi: 10.1126/science.1111420. No abstract available.](https://pubmed.ncbi.nlm.nih.gov/16109872)\n-\n[Kienle GS, Albonico HU, Baars E, Hamre HJ, Zimmermann P, Kiene H. Anthroposophic medicine: an integrative medical system originating in europe. Glob Adv Health Med. 2013 Nov;2(6):20-31. doi: 10.7453/gahmj.2012.087.](https://ichgcp.net/es/clinical-trials-registry/publications/134929-anthroposophic-medicine-an-integrative-medical-system-originating-in-europe)\nFechas de registro del estudio\nFechas importantes del estudio\nInicio del estudio\nFinalizaci\u00f3n primaria (ACTUAL)\nFinalizaci\u00f3n del estudio (ACTUAL)\nFechas de registro del estudio\nEnviado por primera vez\nPrimero enviado que cumpli\u00f3 con los criterios de control de calidad\nPublicado por primera vez (ESTIMAR)\nActualizaciones de registros de estudio\n\u00daltima actualizaci\u00f3n publicada (ESTIMAR)\n\u00daltima actualizaci\u00f3n enviada que cumpli\u00f3 con los criterios de control de calidad\n\u00daltima verificaci\u00f3n\nM\u00e1s informaci\u00f3n\nT\u00e9rminos relacionados con este estudio\nT\u00e9rminos MeSH relevantes adicionales\nOtros n\u00fameros de identificaci\u00f3n del estudio\n- ATS1\nPlan de datos de participantes individuales (IPD)\n\u00bfPlanea compartir datos de participantes individuales (IPD)?\nEsta informaci\u00f3n se obtuvo directamente del sitio web\n[clinicaltrials.gov](https://clinicaltrials.gov) sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comun\u00edquese con [register@clinicaltrials.gov](mailto:register@clinicaltrials.gov). Tan pronto como se implemente un cambio en [clinicaltrials.gov](https://clinicaltrials.gov), tambi\u00e9n se actualizar\u00e1 autom\u00e1ticamente en nuestro sitio web. .\nEnsayos cl\u00ednicos sobre Hipertensi\u00f3n\n-\nNCT06041529A\u00fan no reclutando\n-\nNCT06042439A\u00fan no reclutandoHipertensi\u00f3n\n-\nNCT06042348ReclutamientoRelacionado con el embarazo | Femenino | Humano | Enfermedades de la Placenta, Diagn\u00f3stico\n-\nNCT06039098Reclutamiento\n[Investigaci\u00f3n de la relaci\u00f3n entre la presi\u00f3n intracraneal y el flujo sangu\u00edneo cerebral mediante espectroscopia de correlaci\u00f3n difusa del infrarrojo cercano (ICP-CBF)](https://ichgcp.net/es/clinical-trials-registry/NCT06039098)Lesi\u00f3n cerebral traum\u00e1tica | Hipertensi\u00f3n Intracraneal\n-\nNCT06039176A\u00fan no reclutandoCarrera | Infecciones | Hipertensi\u00f3n | Fragilidad | Arritmias | Insuficiencia cardiaca derecha | DAVI | Sangrado GI\n-\nNCT06038630A\u00fan no reclutandoPolicitemia | Anemia | Enfermedad pulmonar intersticial | Hipertensi\u00f3n Pulmonar Tromboemb\u00f3lica Cr\u00f3nica | Embolia pulmonar aguda\n-\nNCT06038149A\u00fan no reclutandoHipertensi\u00f3n pulmonar\n-\nNCT06034301A\u00fan no reclutandoHipertensi\u00f3n | Adherencia a la medicaci\u00f3n\n-\nNCT06035094A\u00fan no reclutandoPuntuaci\u00f3n de Brain Care, ejercicio, hipertensi\u00f3n, IMC\n-\nNCT06033664A\u00fan no reclutandoHipertensi\u00f3n | Diabetes mellitus tipo 2", "language": null, "image": null, "pagetype": "website", "links": ["https://ichgcp.net/es", "#", "https://ichgcp.net/de", "https://ichgcp.net/", "https://ichgcp.net/es", "https://ichgcp.net/fr", "https://ichgcp.net/it", "https://ichgcp.net/pt", "https://ichgcp.net/ru", "https://ichgcp.net/es/guidance-for-industry-investigator-responsibilities-protecting-the-rights-safety-and-welfare-of-study-subjects", "https://ichgcp.net/es/guidance-for-the-notification-of-serious-breaches-of-gcp-or-the-trial-protocol", "https://ichgcp.net/es/national-statement-on-ethical-conduct-in-human-research-2007-updated-2018-nhmrc-australia", "https://ichgcp.net/es/ministerial-ordinance-on-good-clinical-practice-for-drugs-pharmaceuticals-and-medical-devices-agency-japan", "https://ichgcp.net/es/ich-e-group-of-guidelines", "https://ichgcp.net/es/cro-list", "https://ichgcp.net/es/clinical-trials-registry", "https://ichgcp.net/es/eu-clinical-trials-registry", "https://ichgcp.net/es/pharma-list", "https://ichgcp.net/es/labs", "https://ichgcp.net/es/service-companies", "https://ichgcp.net/es/events", "https://ichgcp.net/es/clinical-trials-registry/publications", "https://ichgcp.net/es/clinical-trials-registry/researchers", "https://ichgcp.net/es/cra-jobs", "https://ichgcp.net/es/publications", "https://ichgcp.net/es/news", "https://ichgcp.net/clinical-trials-registry/NCT02681484", "https://telegram.me/share/url?url=https://ichgcp.net/es/clinical-trials-registry/NCT02681484&text=", "https://twitter.com/intent/tweet?url=https://ichgcp.net/es/clinical-trials-registry/NCT02681484", "https://ichgcp.net/es", "https://ichgcp.net/es/clinical-trials-registry", "https://ichgcp.net/es/clinical-trials-registry/research/list?spons=Klinik%20Arlesheim", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Hypertension", "https://ichgcp.net/es/clinical-trials-registry/research/list?intr=Anthroposophic%20speech%20therapy", "https://ichgcp.net/es/clinical-trials-registry/research/list?intr=Anthroposophic%20speech%20therapy", "https://ichgcp.net/es/clinical-trials-registry/research/list?intr=Anthroposophic%20speech%20therapy", "https://ichgcp.net/es/clinical-trials-registry/research/list?spons=Klinik%20Arlesheim", "https://ichgcp.net/es/clinical-trials-registry/research/list?spons=University%20of%20Bern", "https://ichgcp.net/es/clinical-trials-registry/research/list?spons=Paracelsus-Spital%20Richterswil", "https://ichgcp.net/es/clinical-trials-registry/publications/134925-self-reported-health-characteristics-and-medication-consumption-by-cam-users-and-nonusers-a-swiss", "https://pubmed.ncbi.nlm.nih.gov/23608661", "https://pubmed.ncbi.nlm.nih.gov/10523349", "https://pubmed.ncbi.nlm.nih.gov/11346215", "https://ichgcp.net/es/clinical-trials-registry/publications/134926-reframing-placebo-in-research-and-practice", "https://ichgcp.net/es/clinical-trials-registry/publications/134927-effect-of-rosary-prayer-and-yoga-mantras-on-autonomic-cardiovascular-rhythms-comparative-study", "https://pubmed.ncbi.nlm.nih.gov/18843164", "https://pubmed.ncbi.nlm.nih.gov/25011731", "https://pubmed.ncbi.nlm.nih.gov/10669691", "https://ichgcp.net/es/clinical-trials-registry/publications/57931-heart-rate-variability-a-noninvasive-electrocardiographic-method-to-measure-the-autonomic-nervous", "https://pubmed.ncbi.nlm.nih.gov/9401419", "https://pubmed.ncbi.nlm.nih.gov/8737210", "https://pubmed.ncbi.nlm.nih.gov/14634268", "https://pubmed.ncbi.nlm.nih.gov/23700977", "https://pubmed.ncbi.nlm.nih.gov/19398070", "https://ichgcp.net/es/clinical-trials-registry/publications/134928-oscillations-of-heart-rate-and-respiration-synchronize-during-poetry-recitation", "https://pubmed.ncbi.nlm.nih.gov/12104068", "https://pubmed.ncbi.nlm.nih.gov/11509858", "https://pubmed.ncbi.nlm.nih.gov/11319675", "https://pubmed.ncbi.nlm.nih.gov/16596315", "https://pubmed.ncbi.nlm.nih.gov/22903810", "https://pubmed.ncbi.nlm.nih.gov/16109872", "https://ichgcp.net/es/clinical-trials-registry/publications/134929-anthroposophic-medicine-an-integrative-medical-system-originating-in-europe", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Cardiovascular%20Diseases", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Vascular%20Diseases", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Hypertension", "https://clinicaltrials.gov", "mailto:register@clinicaltrials.gov", "https://clinicaltrials.gov", "https://ichgcp.net/es/clinical-trials-registry/NCT06041529", "https://ichgcp.net/es/clinical-trials-registry/NCT06042439", "https://ichgcp.net/es/clinical-trials-registry/NCT06042348", "https://ichgcp.net/es/clinical-trials-registry/NCT06039098", "https://ichgcp.net/es/clinical-trials-registry/NCT06039176", "https://ichgcp.net/es/clinical-trials-registry/NCT06038630", "https://ichgcp.net/es/clinical-trials-registry/NCT06038149", "https://ichgcp.net/es/clinical-trials-registry/NCT06034301", "https://ichgcp.net/es/clinical-trials-registry/NCT06035094", "https://ichgcp.net/es/clinical-trials-registry/NCT06033664", "https://ichgcp.net/es/clinical-trials-registry/research/list?spons=M.D.%2BAnderson%2BCancer%2BCenter", "https://ichgcp.net/es/clinical-trials-registry/research/list?spons=Medtronic%2BSurgical%2BTechnologies", "https://ichgcp.net/es/clinical-trials-registry/research/list?spons=AstraZeneca", "https://ichgcp.net/es/clinical-trials-registry/research/list?spons=Kaneka%2BAmericas%2BHolding%2BInc.", "https://ichgcp.net/es/clinical-trials-registry/research/list?spons=SeeCure%2BLLC", "https://ichgcp.net/es/clinical-trials-registry/research/list?spons=Universidad%2Bdel%2BZulia", "https://ichgcp.net/es/clinical-trials-registry/research/list?spons=Orphanetics%2BPharma%2BEntwicklungs%2BGmbH", "https://ichgcp.net/es/clinical-trials-registry/research/list?spons=Novartis%2BPharmaceuticals", "https://ichgcp.net/es/clinical-trials-registry/research/list?spons=Cairo%2BUniversity", "https://ichgcp.net/es/clinical-trials-registry/research/list?spons=Universidade%2Bde%2BLisboa%252C%2BPortugal", "https://ichgcp.net/es/clinical-trials-registry/research/list?spons=Assiut%2BUniversity", "https://ichgcp.net/es/clinical-trials-registry/research/list?spons=Mayo%2BClinic", "https://ichgcp.net/es/clinical-trials-registry/research/list?spons=Jos%25C3%25A9phine%2BSOLTANI%252C%2BCardiology%2Bdepartment%252C%2BVersailles%2BHospital", "https://ichgcp.net/es/clinical-trials-registry/research/list?spons=GlaxoSmithKline", "https://ichgcp.net/es/clinical-trials-registry/research/list?spons=Pediatric%2BOrthopaedic%2BSociety%2Bof%2BNorth%2BAmerica", "https://ichgcp.net/es/clinical-trials-registry/research/list?spons=Pfizer", "https://ichgcp.net/es/clinical-trials-registry/research/list?spons=Center%2Bfor%2BIndustrial%2BTechnological%2BDevelopment%2Bof%2BSpain", "https://ichgcp.net/es/clinical-trials-registry/research/list?spons=Assistance%2BPublique%2B-%2BH%25C3%25B4pitaux%2Bde%2BParis", "https://ichgcp.net/es/clinical-trials-registry/research/list?spons=National%2BCancer%2BInstitute%2B%2528NCI%2529", "https://ichgcp.net/es/clinical-trials-registry/research/list?spons=European%2BSociety%2Bof%2BHuman%2BReproduction%2Band%2BEmbryology", "https://ichgcp.net/es/clinical-trials-registry/research/browse/spns_alpha_all", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Hypertension", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Cushing%2527s%2BSyndrome%2BI", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Post-traumatic%2BAnosmia", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Ankle%2BArthroplasty", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Breast%2BCancer", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Stage%2BI%2BGallbladder%2BCancer%2BAJCC%2Bv8", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Pain", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Ultrasound%2BEvaluation", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Postneoadjuvant%2BTherapy%2BStage%2BI%2BGastric%2BCancer%2BAJCC%2Bv8", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Asthma", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Carcinoma%252C%2BAdrenal%2BCortical", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Stroke", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Depression", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Coronary%2BArtery%2BDisease", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Prostate%2BCancer", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Colon%2BMalignant%2BTumor", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Malignant%2BNeoplasm%2Bof%2BRespiratory%2Band%2BIntrathoracic%2BOrgan%2BCarcinoma", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Esophageal%2BResection%2BCandidates", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=HIV%2BInfections", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Obesity", "https://ichgcp.net/es/clinical-trials-registry/research/browse/cond_alpha_all", "https://ichgcp.net/es/clinical-trials-registry/research/list?intr=Carboplatin", "https://ichgcp.net/es/clinical-trials-registry/research/list?intr=Teicoplanin%2BSandoz%2B200%2Bmg%2Bpowder%2Band%2Bsolvent%2Bfor%2Bsolution%2Bfor%2Binjection%2Bor%2Binfusion%2Bor%2Boral%2Bsolution.", "https://ichgcp.net/es/clinical-trials-registry/research/list?intr=Cyclophosphamide", "https://ichgcp.net/es/clinical-trials-registry/research/list?intr=Brimonidine%2Btartrate%2Bophthalmic%2Bsolution%2B0.025%2525%2B%2528n%2B%253D%2B56%2529", "https://ichgcp.net/es/clinical-trials-registry/research/list?intr=Dexamethasone", "https://ichgcp.net/es/clinical-trials-registry/research/list?intr=Paclitaxel", "https://ichgcp.net/es/clinical-trials-registry/research/list?intr=Valacyclovir%2Barrow", "https://ichgcp.net/es/clinical-trials-registry/research/list?intr=Capecitabine", "https://ichgcp.net/es/clinical-trials-registry/research/list?intr=Docetaxel", "https://ichgcp.net/es/clinical-trials-registry/research/list?intr=Gemcitabine", "https://ichgcp.net/es/clinical-trials-registry/research/list?intr=Oral%2BGlucose%2BGel", "https://ichgcp.net/es/clinical-trials-registry/research/list?intr=MK-8521%2B100%25CE%25BCg", "https://ichgcp.net/es/clinical-trials-registry/research/list?intr=Pilocarpine%2B1.25%2525%2BEye%2Bdrop", "https://ichgcp.net/es/clinical-trials-registry/research/list?intr=Transplant%2B2%2BMelphalan", "https://ichgcp.net/es/clinical-trials-registry/research/list?intr=20mg%2BAzilsartan%2BTablets", "https://ichgcp.net/es/clinical-trials-registry/research/list?intr=Cisplatin", "https://ichgcp.net/es/clinical-trials-registry/research/list?intr=Injectafer", "https://ichgcp.net/es/clinical-trials-registry/research/list?intr=Bevacizumab", "https://ichgcp.net/es/clinical-trials-registry/research/list?intr=Prednisone", "https://ichgcp.net/es/clinical-trials-registry/research/list?intr=Alpelisib%2B150%2BMG%2BOral%2BTablet%2B%255BPiqray%255D", "https://ichgcp.net/es/clinical-trials-registry/research/browse/intr_alpha_all", "https://ichgcp.net/es/cro-list/country/angola", "https://ichgcp.net/es/cro-list/country/austria", "https://ichgcp.net/es/cro-list/country/bulgaria", "https://ichgcp.net/es/cro-list/country/ecuador", "https://ichgcp.net/es/cro-list/country/estonia", "https://ichgcp.net/es/cro-list/country/gabon", "https://ichgcp.net/es/cro-list/country/gambia", "https://ichgcp.net/es/cro-list/country/mexico", "https://ichgcp.net/es/cro-list/country/morocco", "https://ichgcp.net/es/cro-list/country/paraguay", "https://ichgcp.net/es/cro-list/country/philippines", "https://ichgcp.net/es/cro-list/country/tanzania", "https://ichgcp.net/es/cro-list/country/turkey", "https://ichgcp.net/es/cro-list", "https://ichgcp.net/es/cro-list/country/el_salvador/company/sgs", "https://ichgcp.net/es/cro-list/country/el_salvador", "https://ichgcp.net/es/clinical-trials-registry/research/browse/cond_alpha_all", "https://ichgcp.net/es/clinical-trials-registry/research/browse/cond_cat", "https://ichgcp.net/es/clinical-trials-registry/research/browse/ord_alpha_all", "https://ichgcp.net/es/clinical-trials-registry/research/browse/intr_alpha_all", "https://ichgcp.net/es/clinical-trials-registry/research/browse/intr_cat", "https://ichgcp.net/es/clinical-trials-registry/research/browse/diet_alpha_all", "https://ichgcp.net/es/clinical-trials-registry/research/browse/diet_cat", "https://ichgcp.net/es/clinical-trials-registry/research/browse/spns_alpha_all", "https://ichgcp.net/es/clinical-trials-registry/research/browse/spns_cat", "https://ichgcp.net/es/clinical-trials-registry/research/browse/locn_alpha_all", "https://ichgcp.net/es/clinical-trials-registry/research/browse/locn_cat", "https://ichgcp.net/es", "https://ichgcp.net/es/guidance-for-industry-investigator-responsibilities-protecting-the-rights-safety-and-welfare-of-study-subjects", "https://ichgcp.net/es/guidance-for-the-notification-of-serious-breaches-of-gcp-or-the-trial-protocol", "https://ichgcp.net/es/national-statement-on-ethical-conduct-in-human-research-2007-updated-2018-nhmrc-australia", "https://ichgcp.net/es/ministerial-ordinance-on-good-clinical-practice-for-drugs-pharmaceuticals-and-medical-devices-agency-japan", "https://ichgcp.net/es/guideline-for-the-notification-of-serious-breaches-of-regulation-eu-no-536-2014", "https://ichgcp.net/es/cro-list", "https://ichgcp.net/es/pharma-list", "https://ichgcp.net/es/labs", "https://ichgcp.net/es/service-companies", "https://ichgcp.net/es/cra-jobs", "https://ichgcp.net/es/clinical-trials-registry", "https://ichgcp.net/es/eu-clinical-trials-registry", "https://ichgcp.net/es/publications", "https://ichgcp.net/es/news", "https://ichgcp.net/about-us-our-mission", "https://ichgcp.net/es/sitemap", "https://ichgcp.net/es/contact-us", "https://ichgcp.net/es/feed", "/privacy", "/disclaimer", "https://ichgcp.net/da/clinical-trials-registry/NCT02681484", "https://ichgcp.net/de/clinical-trials-registry/NCT02681484", "https://ichgcp.net/clinical-trials-registry/NCT02681484", "https://ichgcp.net/es/clinical-trials-registry/NCT02681484", "https://ichgcp.net/fr/clinical-trials-registry/NCT02681484", "https://ichgcp.net/it/clinical-trials-registry/NCT02681484", "https://ichgcp.net/hu/clinical-trials-registry/NCT02681484", "https://ichgcp.net/nl/clinical-trials-registry/NCT02681484", "https://ichgcp.net/no/clinical-trials-registry/NCT02681484", "https://ichgcp.net/pl/clinical-trials-registry/NCT02681484", "https://ichgcp.net/pt/clinical-trials-registry/NCT02681484", "https://ichgcp.net/fi/clinical-trials-registry/NCT02681484", "https://ichgcp.net/sv/clinical-trials-registry/NCT02681484", "https://ichgcp.net/cs/clinical-trials-registry/NCT02681484", "https://ichgcp.net/ru/clinical-trials-registry/NCT02681484", "https://ichgcp.net/ja/clinical-trials-registry/NCT02681484", "https://ichgcp.net/zh/clinical-trials-registry/NCT02681484", "https://ichgcp.net/ko/clinical-trials-registry/NCT02681484", "https://ichgcp.net/pdf/privacy_cookies_policy.pdf", "https://ichgcp.net/pdf/terms_of_service.pdf", "https://ichgcp.net/pdf/privacy_cookies_policy.pdf", "https://ichgcp.net/pdf/terms_of_service.pdf"]}